Cite
HARVARD Citation
Zhang, X. et al. (2019). Safety and Efficacy in Relapsed or Refractory Classic Hodgkin's Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical Trials. BioMed research international. p. . [Online].